BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 1849165)

  • 1. Varicella-zoster virus-specific immunity after herpes zoster.
    Hayward A; Levin M; Wolf W; Angelova G; Gilden D
    J Infect Dis; 1991 Apr; 163(4):873-5. PubMed ID: 1849165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccination of immunocompetent elderly subjects with a live attenuated Oka strain of varicella zoster virus: a randomized, controlled, dose-response trial.
    Trannoy E; Berger R; Holländer G; Bailleux F; Heimendinger P; Vuillier D; Creusvaux H
    Vaccine; 2000 Feb; 18(16):1700-6. PubMed ID: 10689152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered phenotype and functionality of varicella zoster virus-specific cellular immunity in individuals with active infection.
    Schub D; Janssen E; Leyking S; Sester U; Assmann G; Hennes P; Smola S; Vogt T; Rohrer T; Sester M; Schmidt T
    J Infect Dis; 2015 Feb; 211(4):600-12. PubMed ID: 25180236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased incidence of herpes zoster in patients on renal replacement therapy cannot be explained by intrinsic defects of cellular or humoral immunity to varicella-zoster virus.
    Rondaan C; de Joode AAE; van Assen S; Bos NA; Westerhuis R; Westra J
    Antiviral Res; 2018 Oct; 158():206-212. PubMed ID: 30102958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a live attenuated varicella vaccine to boost varicella-specific immune responses in seropositive people 55 years of age and older: duration of booster effect.
    Levin MJ; Barber D; Goldblatt E; Jones M; LaFleur B; Chan C; Stinson D; Zerbe GO; Hayward AR
    J Infect Dis; 1998 Nov; 178 Suppl 1():S109-12. PubMed ID: 9852987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.
    Levin MJ; Oxman MN; Zhang JH; Johnson GR; Stanley H; Hayward AR; Caulfield MJ; Irwin MR; Smith JG; Clair J; Chan IS; Williams H; Harbecke R; Marchese R; Straus SE; Gershon A; Weinberg A;
    J Infect Dis; 2008 Mar; 197(6):825-35. PubMed ID: 18419349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune response of elderly individuals to a live attenuated varicella vaccine.
    Levin MJ; Murray M; Rotbart HA; Zerbe GO; White CJ; Hayward AR
    J Infect Dis; 1992 Aug; 166(2):253-9. PubMed ID: 1321859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic varicella zoster virus reactive effector memory T-cells impaired in the elderly and in kidney transplant recipients.
    van Besouw NM; Verjans GM; Zuijderwijk JM; Litjens NH; Osterhaus AD; Weimar W
    J Med Virol; 2012 Dec; 84(12):2018-25. PubMed ID: 23080511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.
    Weinberg A; Zhang JH; Oxman MN; Johnson GR; Hayward AR; Caulfield MJ; Irwin MR; Clair J; Smith JG; Stanley H; Marchese RD; Harbecke R; Williams HM; Chan IS; Arbeit RD; Gershon AA; Schödel F; Morrison VA; Kauffman CA; Straus SE; Schmader KE; Davis LE; Levin MJ;
    J Infect Dis; 2009 Oct; 200(7):1068-77. PubMed ID: 19712037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
    Levin MJ; Schmader KE; Pang L; Williams-Diaz A; Zerbe G; Canniff J; Johnson MJ; Caldas Y; Cho A; Lang N; Su SC; Parrino J; Popmihajlov Z; Weinberg A
    J Infect Dis; 2016 Jan; 213(1):14-22. PubMed ID: 26452397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum immunoglobulin A antibody to varicella-zoster virus in subjects with primary varicella and herpes zoster infections and in immune subjects.
    Wittek AE; Arvin AM; Koropchak CM
    J Clin Microbiol; 1983 Nov; 18(5):1146-9. PubMed ID: 6315766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization of the elderly to boost immunity against varicella-zoster virus (VZV) as assessed by VZV skin test reaction.
    Takahashi M; Kamiya H; Asano Y; Shiraki K; Baba K; Otsuka T; Hirota T; Yamanishi K
    Arch Virol Suppl; 2001; (17):161-72. PubMed ID: 11339545
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subclinical varicella-zoster virus viremia, herpes zoster, and T lymphocyte immunity to varicella-zoster viral antigens after bone marrow transplantation.
    Wilson A; Sharp M; Koropchak CM; Ting SF; Arvin AM
    J Infect Dis; 1992 Jan; 165(1):119-26. PubMed ID: 1309369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella-zoster virus (VZV)-specific cytotoxicity after immunization of nonimmune adults with Oka strain attenuated VZV vaccine.
    Hayward A; Villanueba E; Cosyns M; Levin M
    J Infect Dis; 1992 Aug; 166(2):260-4. PubMed ID: 1321860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major depressive disorder and immunity to varicella-zoster virus in the elderly.
    Irwin MR; Levin MJ; Carrillo C; Olmstead R; Lucko A; Lang N; Caulfield MJ; Weinberg A; Chan IS; Clair J; Smith JG; Marchese RD; Williams HM; Beck DJ; McCook PT; Johnson G; Oxman MN
    Brain Behav Immun; 2011 May; 25(4):759-66. PubMed ID: 21329753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-mediated immunity to varicella-zoster virus.
    Arvin AM
    J Infect Dis; 1992 Aug; 166 Suppl 1():S35-41. PubMed ID: 1320649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VZV T cell-mediated immunity.
    Weinberg A; Levin MJ
    Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Persistence of Varicella-Zoster Virus-Specific Plasma Cells in Adult Human Bone Marrow following Childhood Vaccination.
    Eberhardt CS; Wieland A; Nasti TH; Grifoni A; Wilson E; Schmid DS; Pulendran B; Sette A; Waller EK; Rouphael N; Ahmed R
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32321817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proliferative response to varicella-zoster virus is inverse related to development of high levels of varicella-zoster virus specific IgG antibodies.
    Terada K; Kawano S; Yoshihiro K; Morita T
    Scand J Infect Dis; 1993; 25(6):775-8. PubMed ID: 8052820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Altered cellular and humoral immunity to varicella-zoster virus in patients with autoimmune diseases.
    Rondaan C; de Haan A; Horst G; Hempel JC; van Leer C; Bos NA; van Assen S; Bijl M; Westra J
    Arthritis Rheumatol; 2014 Nov; 66(11):3122-8. PubMed ID: 25223407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.